Primary Care On Demand: Obesity Vol. 2
|
$135.20
Use promo code (Limited Offer)
5 CREDITS
  Hurry! Offer expires September 15, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from recent conferencesCourse Content
| Session | Title | Faculty |
| Session 1 (59 minutes) | Update on New Treatment Options for Weight Management | K. Fujioka, MD |
| Session 2 (98 minutes) | Evidence-based Obesity Management in Primary Care: A Patient-Centered A-B-C-D-E-F Framework | S. Kahan, MD |
| Session 3 (37 minutes) | Obesity: Blame it on the Brain | D. Ryan, MD |
| Session 4 (50 minutes) | The Role of Lifestyle Interventions in the Treatment of Obesity: Implementing Practical Therapies into Clinical Practice | C. Still, DO |
| Session 5 (64 minutes) | Medical Management of Common Co-Morbid Problems of Obesity | K. Fujioka, MD |
Program Overview
Primary Care On Demand: Obesity Volume 2 will educate and promote improved patient outcomes for weight related issues commonly encountered in internal medicine and family medicine practice. This CME course will highlight the latest science related to obesity and weight management, presented in a practical and patient-focused manner relevant to the primary care setting. It reviews the clinical presentation and management strategies of commonly encountered obesity issues.
Presented by Continuing Education Company (CEC) for the past 29 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity, Primary Care On Demand: Obesity Volume 2 is comprised of recorded video lectures taken from various recent live Primary Care conferences presented by CEC.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide patients with an accurate diagnosis and optimal care for obesity as seen in primary care.
- Communicate more confidently to patients regarding their weight and obesity associated health problems.
- Develop evidence-based interventions and treatment strategies to improve the health and well-being of patients with obesity.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate.
Faculty
Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center
Center of Weight Management
Diabetes and Endocrinology
Scripps Clinic Medical Group
San Diego, CA
Scott Kahan, MD, MPH
Director, National Center for Weight and Wellness
Medical Director, Strategies to Overcome and Prevent (STOP) Obesity Alliance
Johns Hopkins University/George Washington University
Washington, DC
Donna H. Ryan, MD, FACP
Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, LA
Vallejo, CA
Christopher D. Still, DO, FACN, FACP, FTOS
Director, Geisinger Obesity Institute
Medical Director, Center for Nutrition and Weight Management
Medical Director, Employee Wellness
Associate, Department of Gastroenterology and Nutrition
Geisinger Health Care System
Danville, PA
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company, Inc. designates this enduring material for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST complete the activity and the evaluation form. For ABIM MOC points, your information will be shared with the ABIM through the ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 5 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 5 hours of participation, 3 of which can be used towards Pharmacology, for completing this activity.
Release Date: 10/21/2021
Expiration Date: 10/21/2024 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major – Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Ken Fujioka, MD | Consultant: Amgen, Boehringer-Ingelheim, Gelesis Janssen Global Services, Phenomix, and Sunovion Pharmaceuticals Consultant, Speakers Bureau: Takeda Advisory Board, Consultant, Speakers Bureau: Novo Nordisk |
| Scott Kahan, MD | Consultant: Gelesis, Lilly, Novo Nordisk, Pfizer, and Vivus |
| Donna Ryan, MD | Advisory Board: Janssen
Advisory Board, Consultant: Wondr Health Advisory Board, Speakers Bureau: Novo Nordisk Consultant: Bausch Health, Boehringer Ingelheim, IFA Celtic, Real Appeal, Roman, and Sanofi Consultant, Ownership Interest: Calibrate (ReDesign Health), Epitomee, Gila Therapeutics, Phenomix, Scientific Intake and Xeno Biosciences |
| Christopher Still, DO | Consultant: Covidien Research Grant: Ethicon-Endosurgery Consultant, Speakers Bureau: Novo Nordisk |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.